Glades Drugs Recalls Vitamin D3 Supplement Due to Excessive Potency
Glades Drugs Inc. is recalling Vitamin D3 supplement capsules because they contain an extremely high level of vitamin D3.
The agency’s classification
FDA (Drugs): Class I
Class I is a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 5/5 (Critical).
Highest-severity recall. The hazard can cause serious injury or death. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The source text explicitly identifies the agency classification as Class I, which mandates a severity score of 5 according to the rubric.
Plain-English summary
Glades Drugs Inc. is recalling Vitamin Supplement (Vial) D3 capsules, which contain cholecalciferol (vitamin D3), lipoic acid, ubiquinol, methylcobalamin, pyridoxine, methionine, inositol, and choline bitartrate USP. The recall involves 60, 120, or 180 count vials. The total quantity affected is 7,800 capsules.
The FDA has classified this as a Class I recall because the product is a superpotent drug, meaning it contains an extremely high level of vitamin D3. This excessive potency poses a significant risk of adverse health consequences to consumers.
The affected products were distributed in New York and Georgia. Consumers should stop using the recalled capsules and check their lot codes against the list provided by the FDA, which includes codes such as AICACABF@3 and AICECABF@2, with an expiration date of 02/20/2016.
The recalled product
- Product
- Vitamin Supplement (Vial) D3, (cholecalciferol (vit D3)/lipoic acid/ubiquinol/ methylcobalamin/pyridoxine/methionine/inositol/choline bitartrate USP) capsules, 60, 120 or 180 count vials, Glades Drugs, 109 S. Lake Ave., Pahokee, FL 33476.
- Manufacturer
- Glades Drugs Inc.
- Category
- Drug — Vitamin Supplement
- Affected units
- 7,800
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- AICACABF@3
- AICECABF@2
- AJBFCABF@4
- ABCCABF@4
- AICACABF@5
- AICECABF@3
- AJBHCABF@2
- ABCCABF@5
- AICBCABF@1
- AICECABF@4
- AJCBCABF@1
- ABGCABF@4
- AICBCABF@2
- AICECABF@5
- JCBCABF@2
- BACDCABF@5
- AICBCABF@3
- AICICABF@3
- BAAGCABF@2
- BADACABF@3
Distribution
Related recalls
Other drug recalls
- SevereK.C. Pharmaceuticals Recalls Target Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- LowSun Pharmaceutical Recalls Tretinoin Cream Due to Impurity Failures
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereGreen Valley Drugs Recalls Vitamin D3 Injections Due to Sterility Concerns
FDA (Drugs) · 2013-05-22
- LowVitamin Shoppe Recalls Calcium Citrate Plus Magnesium & Vitamin D Supplements
FDA (Food) · 2020-08-12
- HighInjectable Vitamin D3 Recalled Over Sterility Concerns at Manufacturing Facility
FDA (Drugs) · 2023-02-01
- ModeratePharmatech Recalls D3 Vitamin Liquid Due to Potential B. cepacia Contamination
FDA (Food) · 2016-11-02
- ModerateHealthprint Vitamin D3 5000 recalled for sub-potency and incorrect labeling
FDA (Food) · 2024-03-06
- SeverePromise Pharmacy Recalls Vitamin D3 Injections Due to Sterility Concerns
FDA (Drugs) · 2019-02-20